Influenza A Virus, H3N2 Subtype
"Influenza A Virus, H3N2 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.
| Descriptor ID |
D053122
|
| MeSH Number(s) |
B04.820.545.405.400.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Influenza A Virus, H3N2 Subtype".
Below are MeSH descriptors whose meaning is more specific than "Influenza A Virus, H3N2 Subtype".
This graph shows the total number of publications written about "Influenza A Virus, H3N2 Subtype" by people in this website by year, and whether "Influenza A Virus, H3N2 Subtype" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 2 | 4 |
| 2008 | 3 | 1 | 4 |
| 2009 | 2 | 3 | 5 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 2 | 5 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
| 2014 | 4 | 0 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 3 | 2 | 5 |
| 2017 | 5 | 0 | 5 |
| 2018 | 3 | 2 | 5 |
| 2019 | 0 | 6 | 6 |
| 2020 | 3 | 4 | 7 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 7 | 7 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Influenza A Virus, H3N2 Subtype" by people in Profiles.
-
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season. J Infect Dis. 2025 Feb 04; 231(1):e123-e131.
-
Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States. Emerg Infect Dis. 2024 Nov; 30(11):2303-2312.
-
Random-Effects Substitution Models for Phylogenetics via Scalable Gradient Approximations. Syst Biol. 2024 Sep 05; 73(3):562-578.
-
Integrated epigenomic exposure signature discovery. Epigenomics. 2024; 16(14):1013-1029.
-
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients. Blood Adv. 2024 04 23; 8(8):1880-1892.
-
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clin Infect Dis. 2024 Apr 10; 78(4):1056-1064.
-
Scalable gradients enable Hamiltonian Monte Carlo sampling for phylodynamic inference under episodic birth-death-sampling models. PLoS Comput Biol. 2024 Mar; 20(3):e1011640.
-
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis. 2024 01 25; 78(1):217-226.
-
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. Nat Commun. 2023 09 27; 14(1):6030.
-
Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent Influenza Vaccine in Older Nursing Home Residents. J Infect Dis. 2023 09 15; 228(6):704-714.